|
PHF10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53172999999285E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.984400E-04 |
| Normal-vs-Stage2 |
8.34419999999891E-05 |
| Normal-vs-Stage3 |
4.67779999957507E-07 |
| Normal-vs-Stage4 |
1.31020000004867E-06 |
| Stage1-vs-Stage2 |
1.631040E-01 |
| Stage1-vs-Stage3 |
2.522000E-02 |
| Stage1-vs-Stage4 |
4.636300E-02 |
| Stage2-vs-Stage3 |
8.205600E-01 |
| Stage2-vs-Stage4 |
9.713000E-01 |
| Stage3-vs-Stage4 |
8.106800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.31639999995303E-06 |
| Normal-vs-AfricanAmerican |
2.138000E-01 |
| Normal-vs-Asian |
8.759300E-03 |
| Caucasian-vs-AfricanAmerican |
9.397700E-02 |
| Caucasian-vs-Asian |
2.724000E-01 |
| AfricanAmerican-vs-Asian |
4.804800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.06789999995993E-06 |
| Normal-vs-Female |
3.95960000000306E-05 |
| Male-vs-Female |
5.903200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.136320E-03 |
| Normal-vs-Age(41-60Yrs) |
4.46210000000224E-05 |
| Normal-vs-Age(61-80Yrs) |
1.49590000053657E-07 |
| Normal-vs-Age(81-100Yrs) |
5.024900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.320000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.417500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.596200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.026200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.673000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.278600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.441000E-04 |
| Classical-VS-Follicular |
6.18430000000059E-05 |
| Classical-VS-Other |
5.996400E-01 |
| Classical-VS-Normal |
1.618600E-03 |
| Tall-VS-Follicular |
7.426200E-01 |
| Tall-VS-Other |
4.364600E-01 |
| Tall-VS-Normal |
8.89169999962469E-07 |
| Follicular-VS-Other |
4.603600E-01 |
| Follicular-VS-Normal |
2.28909999955285E-07 |
| Other-VS-Normal |
8.691900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.22339999978294E-07 |
| Normal-vs-N1 |
3.358100E-04 |
| N0-vs-N1 |
6.696600E-01 |
|
|
